(2010). A: Observed and predicted growth responses in prepubertal children with growth disorders: guidance of growth hormone treatment by empirical variables.
(2002). Adult height after long term treatment with recombinant growth hormone for idiopathic isolated growth hormone deficiency: observational follow up study of the French population based registry. BMJ
(2007). AlbertssonWikland K: Models predicting the growth response to growth hormone treatment in short children independent of GH status, birth size and gestational age. BMC Med Inform Decis Mak
(2000). Bramswig JH: Prediction of growth response in prepubertal children treated with growth hormone for idiopathic growth hormone deficiency. Acta Paediatr
(2009). Cianfarani S: Impact of growth hormone therapy on adult height of children born small for gestational age. Pediatrics
(2009). Cicognani A: Developmental syndromes: growth hormone deficiency and treatment. Endocr Dev
(2010). Current indications for growth hormone therapy for children and adolescents. Endocr Dev
(2004). Cutfield WS: Growth hormone treatment in children: review of safety and efficacy. Paediatr Drugs
(2000). DA: Prediction of long-term response to recombinant human growth hormone in Turner syndrome: development and validation of mathematical models.
(2010). de Muinck Keizer-Schrama SM: Adult height in children with growth hormone deficiency: a randomized, controlled, growth hormone doseresponse trial. Horm Res Paediatr
(1999). Derivation and validation of a mathematical model for predicting the response to exogenous recombinant human growth hormone (GH)
(2007). Dunger DB: Future directions: growth prediction models. Horm Res
(2005). Efficacy and safety results of long-term growth hormone treatment of idiopathic short stature.
(2010). Factors influencing the one- and twoyear growth response in children treated with growth hormone: analysis from an observational study.
for Disease Control and Prevention: Percentile data files with LMS values.[http://www.cdc.gov/growthcharts/percentile_data_files.htm].
(1996). Galasso C: Final height in Turner syndrome patients treated with growth hormone. Horm Res
(2005). Gender does not influence prepubertal growth velocity during standard growth hormone therapy-analysis of United States KIGS data. J Pediatr Endocrinol Metab
(2000). Growth Hormone Research Society: Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary
Growth hormone treatment of idiopathic short stature: clinical studies.
(2008). Growth hormone use in the treatment of idiopathic short stature. Curr Opin Invest Drugs
(2001). Hokken-Koelega AC, Czernichow P: International Small for Gestational Age Advisory Board consensus development conference statement: management of short children born small for gestational age, April 24-October 1,
(2007). Hokken-Koelega AC: Prediction of adult height in growth-hormone-treated children with growth hormone deficiency.
(2009). Lindberg A: Predicting growth in response to growth hormone treatment. Growth Horm IGF Res
(2010). MB: Predicting the response to growth hormone treatment in short children with chronic kidney disease.
(2000). New paradigms for growth hormone treatment in the 21st century: prediction models.
(2010). Norditropin cartridges (somatropin [rDNA origin] injection) for subcutaneous use [prescribing information].
(2003). Prediction of response to growth hormone treatment in short children born small for gestational age: analysis of data from
(1996). Preliminary validation of a prediction model for the short-term growth response to growth hormone therapy in children with idiopathic short stature. Acta Paediatr Suppl
(2007). Recombinant growth hormone for children and adolescents with Turner syndrome. Cochrane Database Syst Rev
(2007). Recombinant growth hormone for idiopathic short stature in children and adolescents. Cochrane Database Syst Rev
(2008). Recombinant human growth hormone for children born small for gestational age: meta-analysis confirms the consistent dose-effect relationship on catch-up growth.
(2007). Reiter EO: Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in idiopathic short stature. Horm Res
(2000). RG: Growth hormone treatment of short children born small for gestational age: growth responses with continuous and discontinuous regimens over 6 years. J Clin Endocrinol Metab
(2009). Rivas-Crespo F: Predicting the growth response of children with idiopathic growth hormone deficiency to one year of recombinant growth hormone treatment: derivation and validation of a useful method. J Pediatr Endocrinol Metab
(2007). Schoenau E: Predicting the growth response to growth hormone (GH) treatment in prepubertal and pubertal children with isolated GH deficiency-model validation in an observational setting (GeNeSIS). J Pediatr Endocrinol Metab
(1998). SL: The growth hormone cascade: progress and long-term results of growth hormone treatment in growth hormone deficiency. Horm Res
(2006). The multiple indications for growth hormone treatment of pediatric patients. Pediatr Ann